Learn more about the scientific background of the most common genome editing tools, and the evolving genome editing market ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

New precision genome editing technologies are transforming the therapeutic landscape for patients with certain cancers and ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have ... Cas12a-knock-in mice for multiplexed genome editing, disease modelling and immune-cell engineering ...

A research team from Helmholtz Munich and the Technical University of Munich has developed an advanced delivery system that ...

Earlier this month Scribe Therapeutics, a developer of CRISPR-based genome and epigenome editing platforms and ... Cas12 nucleases are smaller than Cas9, allowing for easier transporting of ...

The Advances in Genome Biology ... clones for successful editing events using CRISPR-Cas9 techniques. Spectrum Compact CE also supports next-generation 8-color STR kits and can also be used ...

To establish DLD-1 UNG KO cell lines, 2 x 10 5 DLD-1 cells were nucleofected with ribonucleoprotein complexes targeting UNG (UNG gRNA_UNG_4) or HPRT (gRNA_HPRT) using the SE Cell Line 4D-Nucleofector ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

CRISPR-Cas9 gene editing technology has emerged as one of the most transformative advancements in medicine and biotechnology.

CRISPR MarketThe CRISPR Market had an estimated market share worth USD 3.4 billion in 2023, and it is predicted to reach a global market valuation of USD 17.8 billion by 2034, growing at a CAGR of 16.